131030 — Optus Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Optus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	69,555	61,555	57,811	51,408	39,796
Net Total Accounts Receivable
Net Total Receivables	6,564	7,908	9,995	13,753	13,593
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	91,017	81,386	91,772	77,896	67,155
Net Property, Plant And Equipment	38,717	43,735	42,501	56,863	99,296
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	140,038	136,240	149,460	166,503	191,057
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,375	9,760	13,072	21,110	25,603
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	13,018	11,773	15,009	22,768	26,051
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	127,021	124,467	134,451	143,735	165,006
Total Liabilities & Shareholders' Equity	140,038	136,240	149,460	166,503	191,057
Total Common Shares Outstanding